secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0001437749-22-028154
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Isoray loans $6M to Viewpoint at 15%, secures all assets; Viewpoint CEO buys ISR shares
--------------------------------------------------------------------------------

- Isoray loaned $6M to Viewpoint at 15% interest, due Dec 31, 2023, secured by first-priority security interest in all Viewpoint personal property.
- Loan proceeds to be used for Viewpoint business expenses in accordance with a budget approved by Isoray.
- Viewpoint CEO Thijs Spoor and other officers/directors have purchased or may purchase shares of Isoray common stock on the open market.
- The loan is bridge financing ahead of the planned merger of Viewpoint into a wholly owned subsidiary of Isoray (previously announced Sep 27, 2022).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774922028154/0001437749-22-028154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774922028154/isr20221123_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer